Forest Expects Multiple Celexa Generics To Enter Market In January
Executive Summary
Forest Labs is not putting any "impediments" in the way of generic applications for the antidepressant Celexa (citalopram), President Kenneth Goodman told the Friedman Billings Ramsey growth conference June 2 in New York
You may also be interested in...
Antidepressant Safety Concerns Depress Zoloft; Forest, Wyeth Still Happy
Pfizer's Zoloft may feel the greatest negative performance impact from FDA's decision to require a class-wide black box warning for antidepressants
Antidepressant Safety Concerns Depress Zoloft; Forest, Wyeth Still Happy
Pfizer's Zoloft may feel the greatest negative performance impact from FDA's decision to require a class-wide black box warning for antidepressants
Forest Takes On Merck, Novartis In Hypertension; Benicar Another Lexapro?
Forest/Sankyo's Benicar is rivaling Novartis' Diovan in the number of new patient starts in the angiotensin II inhibitor antihypertensive class, Forest President Kenneth Goodman told the Friedman Billings Ramsey growth conference June 2 in New York